Original Contribution |
From the Department of Biomedical Sciences (P.N.T., G.F.N.), Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK, and the School of Biochemistry (F.M.), University of Birmingham, Birmingham, UK.
Correspondence to Graeme F. Nixon, PhD, Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK. E-mail g.f.nixon{at}abdn.ac.uk
AbstractThe recent discoveries of inositol 1,4,5-trisphosphate (IP3) receptor subtypes with different affinities for IP3 and their potential involvement in development has important consequences for vascular smooth muscle. This study has examined the expression and distribution of the type 1 and type 3 IP3 receptor subtypes in developing rat vascular smooth muscles. Immunoblotting of portal vein and aorta from neonatal (2 to 4 days) and fully developed (6 weeks) rats revealed significantly higher levels of the type 3 IP3 receptor expression in neonatal, compared with developed, vascular smooth muscles. In contrast, expression of the type 1 IP3 receptor in neonates was lower compared with developed vascular smooth muscles. Immunolocalization of the type 3 IP3 receptors in neonatal tissues revealed that staining corresponded to the distribution of the sarcoplasmic reticulum (visualized by osmium ferricyanide staining of thin tissue sections), which suggested localization of the type 3 IP3 receptor throughout the sarcoplasmic reticulum network. We conclude that type 3 IP3 receptors are the predominant subtype in the development of vascular smooth muscle and are distributed throughout the sarcoplasmic reticulum in these cells. The switch in isoforms of the IP3 receptor during development from the type 3 with low affinity for IP3 to the higher-affinity type 1 receptor may play a role in calcium-mediated regulation of developing vascular smooth muscle.
Key Words: receptor muscle, smooth, vascular Ins(1,4,5)P3 development
This article has been cited by other articles:
![]() |
R. Berra-Romani, A. Mazzocco-Spezzia, M. V. Pulina, and V. A. Golovina Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture Am J Physiol Cell Physiol, September 1, 2008; 295(3): C779 - C790. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gkogkas, S. Middleton, A. M. Kremer, C. Wardrope, M. Hannah, T. H. Gillingwater, and P. Skehel VAPB interacts with and modulates the activity of ATF6 Hum. Mol. Genet., June 1, 2008; 17(11): 1517 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Afroze, A. M. Sadi, M. A. Momen, S. Gu, S. Heximer, and M. Husain c-Myb-Dependent Inositol 1,4,5-Trisphosphate Receptor Type-1 Expression in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1305 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Bolton Calcium events in smooth muscles and their interstitial cells; physiological roles of sparks J. Physiol., January 1, 2006; 570(1): 5 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Egan, C. L. Wainwright, R. M. Wadsworth, and G. F. Nixon PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: Effects of altered intracellular Ca2+ regulation Cardiovasc Res, August 1, 2005; 67(2): 308 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Wang, Y.-M. Zheng, Q.-B. Mei, Q.-S. Wang, M. L. Collier, S. Fleischer, H.-B. Xin, and M. I. Kotlikoff FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells Am J Physiol Cell Physiol, March 1, 2004; 286(3): C538 - C546. [Abstract] [Full Text] |
||||
![]() |
F. Coussin, R. H. Scott, A. Wise, and G. F. Nixon Comparison of Sphingosine 1-Phosphate-Induced Intracellular Signaling Pathways in Vascular Smooth Muscles: Differential Role in Vasoconstriction Circ. Res., July 26, 2002; 91(2): 151 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Nauli, J. M. Williams, S. E. Akopov, L. Zhang, and W. J. Pearce Developmental changes in ryanodine- and IP3-sensitive Ca2+ pools in ovine basilar artery Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1785 - C1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, J. Chen, Y. Wang, C. W. Taylor, Y. Hirata, H. Hagiwara, K. Mikoshiba, T. Toyo-oka, M. Omata, and Y. Sakaki Crucial Role of Type 1, but Not Type 3, Inositol 1,4,5-Trisphosphate (IP3) Receptors in IP3-Induced Ca2+ Release, Capacitative Ca2+ Entry, and Proliferation of A7r5 Vascular Smooth Muscle Cells Circ. Res., February 2, 2001; 88(2): 202 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Angeles, J. Williams, R. E. Purdy, L. Zhang, and W. J. Pearce Effects of maturation and acute hypoxia on receptor-IP3 coupling in ovine common carotid arteries Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R410 - R417. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, A. S. Clanachan, and B. I. Jugdutt Enhanced Expression of Angiotensin II Type 2 Receptor, Inositol 1,4,5-Trisphosphate Receptor, and Protein Kinase C{epsilon} During Cardioprotection Induced by Angiotensin II Type 2 Receptor Blockade Hypertension, October 1, 2000; 36(4): 506 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Long, L. Zhang, and L. D. Longo Cerebral artery sarcoplasmic reticulum Ca2+ stores and contractility: changes with development Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R860 - R873. [Abstract] [Full Text] [PDF] |
||||
![]() |
Yi Xu, V. Menon, and B. I Jugdutt Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-{varepsilon} in acutely reperfused myocardial infarction in the dog: Effect of UP269-6 and losartan on AT1- and AT2-receptor expression and IP3 receptor and PKC{varepsilon} proteins Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 184 - 195. [Abstract] [PDF] |
||||
![]() |
O. Vallot, L. Combettes, P. Jourdon, J. Inamo, I. Marty, M. Claret, and A.-M. Lompre Intracellular Ca2+ Handling in Vascular Smooth Muscle Cells Is Affected by Proliferation Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1225 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Jugdutt, Yi Xu, M. Balghith, R. Moudgil, and V. Menon Cardioprotection Induced by AT1R Blockade After Reperfused Myocardial Infarction: Association With Regional Increase in AT2R, IP3R and PKC{varepsilon} Proteins and cGMP Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 301 - 311. [Abstract] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |